Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA antidepressant discontinuation timing study
NL-OMON47941Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sertraline, citalopram and Placebo-COD Research Private Ltd in major depressive disorder (MDD) (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Sustained remission time, Severe depressive symptoms / relapse definition and 1 more. Started May 2020; status: active, not recruiting.
02
Drugs
sertralinecitalopramPlacebo-COD Research Private Ltd
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON47941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47941.